RAD51 and hematologic disorder: Furthermore, the same RAD51 variant, RAD51C-G135C, also increases the risk for hematologic malignancies [RAD51-G135C, C versus G: OR 1.16 (95% CI 1.02–1.31), dominant model: OR 1.18 (95% CI 1.03–1.36)] (69).